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Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a major 
threat to the swine industry worldwide and hence global food security, 
exacerbated by a newly emerged highly pathogenic (HP-PRRSV) strain from 
China. PRRSV non-structural protein 2 (nsp2) is a multifunctional polypeptide 
with strain-dependent influences on pathogenicity.  A number of discrete 
functional regions have been identified on the protein.  Quantitative label free 
proteomics was used to identify cellular binding partners of nsp2 expressed by 
HP-PRRSV.  This allowed the identification of potential cellular interacting 
partners and the discrimination of non-specific interactions.  The interactome 
data was further investigated and validated using biological replicates and also 
compared with nsp2 from a low pathogenic (LP) strain of PRRSV.  Validation 
included both forward and reverse pulldowns and confocal microscopy.  The 
data indicated that nsp2 interacted with a number of cellular proteins including; 
14-3-3, CD2AP and other components of cellular aggresomes.  The hyper 
variable region of nsp2 protein was identified as a binding platform for 
association with 14-3-3 proteins. 
Keywords 
Porcine reproductive and respiratory syndrome virus, non-structural protein 2, 
label free proteomics, proteomics, virus, interactome, aggresomes. 
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Introduction 
Approximately 25 years ago, a disease called “mystery swine disease” 
characterized by high fever, disordered respiratory, abortion, and stillborn or 
mummified piglets emerged into Northern American and in Central Europe.1 
The etiologic agent was identified as a positive sense, single-stranded RNA 
virus,2, 3 designated porcine reproductive and respiratory syndrome virus 
(PRRSV); subsequently classified into the order Nidovirales, family 
Arteriviridae, genus.4 After further genomic analysis, two major genotypes 
were identified; the European (type 1) and the North American (type 2) isolates. 
This disease is now found worldwide and causes significant losses in the 
swine industry owing to reproductive disorders and growth retardation.  
PRRSV is prone to mutate and recombine in vivo resulting in new strains, 
complicating its control and eradication.5-7  The emergence of a highly 
pathogenic strain of PRRSV (HP-PRRSV) caused devastating economic 
losses in China in 2006.8, 9 
The genome of PRRSV is approximately 15kb in length and contains ten 
open reading frames (ORFs) in succession: 
ORF1a-ORF1b-ORF2a-ORF2b-ORF3-ORF4-ORF5-ORF5a-ORF6-ORF7.10 
Type 1 and type 2 genotypes are highly diverse, sharing only approximately 60% 
nucleotide identity.11, 12    ORF1a and ORF1b occupy three quarters of the 
whole genome and encode two large replicase precursor polyproteins pp1a 
and pp1ab.  These polyproteins are then processed into 13–16 functional 
non-structural proteins (nsps) by viral proteinases directed by ORF1a .13, 14  
Of these mature polypeptides, nsp2 is the largest cleavage product and 
the most variable in terms of length and amino acid sequence with less than 40% 
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shared at the amino acid level between both genotypes11, due in part to 
intragenic and intergenic recombination.6, 7  These differences contribute to 
virulence and genotyping of PRRSV.8,9,11,12 Nsp2 possesses a cysteine 
protease (PL2) domain, a central hypervariable domain (HV), a 
trans-membrane domain (TM) followed by a tail domain.14, 15  The PL2 domain 
possesses dual characteristics of papain-like cysteine proteases and 
chymotrypsin-like serine proteases and is responsible for cleavage of nsp2/3 
as well as acting as a co-factor of the nsp4 serine protease.10, 16, 17  The PL2 
region is also a member of the ovarian tumour (OTU) protease super-family.  
This family of proteases is thought to be involved in the inhibition of the host 
innate immune response.18 Supporting this for PRRSV, the PRRSV OTU 
domain has been shown to antagonize the induction of type I interferon and is 
capable of deconjugating ubiquitin and ISG15.19   
The HV region located between aa160-844 contributes to the size 
differences observed between different strains and types of PRRSV.10-12  
Mutations, insertions, and more commonly, deletions are observed in this 
region. The genetic marker of HP-PRRSV is the deletion of 30 aa in the central 
part of nsp2.  Analysis has indicated that the central part can tolerate nearly 
400aa (324-726) deletion but cannot be removed as a whole. 20  The 
C-terminal region of nsp2 contains three to four TM domains with unknown 
function, although these may be involved in tethering replication complexes.   
At least 6 isoforms of nsp2 have been detected in PRRSV infected cells; all of 
them were stable and had low turnover rates.21  Despite its name, nsp2 is 
found in virions, suggesting that this protein may also be a virion-associated 
structural protein.22  Nsp2 also contains predominant B cell epitopes and 
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evokes high titer antibody resulting in modulating adaptive immune 
response.23 
Many viral proteins including components of RNA dependent RNA 
polymerase complexes form associations with cellular proteins inside virus 
infected cells.  This can reflect a balance between pro-viral and anti-viral 
activity.  Given the complexity and multi-functional nature of the nsp2 protein 
we hypothesized that it would interact with multiple cellular proteins.  To test 
this, label free quantitative proteomics and other techniques were used to 
identify cellular proteins that potentially formed specific interactions with 
GFP-tagged nsp2 from HP-PRRSV as well as classical low pathogenicity 
strains (LP-PRRSV).  We identified 91 cellular proteins as potential partners 
of nsp2 from HP-PRRSV, including many that were part of larger complexes, 
such as the aggresome.  Notably, this included the 14-3-3 protein family, 
which plays a role in critical regulatory processes in the cell. 
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Experimental Procedures 
 
Cells and virus 
293T, MARC-145 and PK-15 cells were obtained from the Health 
Protection Agency Culture Collections and cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine 
serum at 37°C, 5% CO2 in a humidified incubator.  PRRSV strain of the 
classical low pathogenicity CH-1R and high pathogencity strain SD-16 with 
30-aa deletion in nsp2 gene (isolated from a clinical case in 2007, the genome 
sequence was submitted in GenBank as NO JX087437) were propagated in 
MARC-145 cells.  Viruses were harvested 3 days post-infection and passed 
through 0.22 µm filter.  Virus titre was measured by tissue culture 50% 
infectious dose and calculated by the Reed-Muench method24 depending on 
observation of CPE. HEK293FT (Life Technologies) and MARC-145 (ATCC) 
were used to express and propagate PRRSV-nsp2-GFP (North American type 
1 virus SD01-08),25 respectively.  
 
PRRSV-nsp2-GFP expression and propagation 
HEK293FT cells at about 80% confluency, propagated the day before, were 
transfected with 8µg pSD01-08-GFP plasmid 24 per T75 flask using 
polyethylenimine (PEI, linear, 25,000kDa, Alfa Aesar; 1µg/µl stock 
concentration) transfection reagent at 1:5 ratio.  Medium was replaced 4h 
post transfection by infection medium (2% FBS, 100U/ml Penicillin and 
100µg/ml Streptomycin (Gibco) in DMEM).  Supernatant was harvested 72h 
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post transfection, filtered through a 0.22 µm filter, and buffered with 1M 
HEPES (pH 7.2-7.5, Gibco) to 25mM final concentration before freezing.  
Highly confluent MARC-145 cells were infected with supernatant from 
HEK293FT cells at a 1:10 dilution (approx. MOI=0.0001) in infection medium. 
Inoculum was replaced 2 hours post infection (hpi) and infection allowed to 
continue until 60hpi.  Supernatant was harvested and buffered to 25mM 
HEPES as described above. Virus was passaged two more times at MOI=0.1 
on MARC-145 cells to yield cell adapted virus. Infections and harvests were 
performed as described above, yielding a passage three PRRSV-nsp2-GFP 
stock at 9.3 x 106 TCID50/ml.  Virus infectivity was assessed by endpoint 
dilution on MARC-145 cells. Confluent MARC-145 cells were infected with 
serial dilutions of viral stocks (after 1x freezing cycle) in infection medium.  
Inoculum was replaced 2hpi by infection medium.  Infection was assessed 
48hpi and confirmed 72hpi by visualization of GFP expression using 
fluorescence wide-field microscopy. 
 
Plasmids  
Nsp2 genes were amplified from recombinant plasmids (constructed by 
others in our group) containing the full length of ORF1a by the following 
primers with Bgl Ⅱ  and Sma Ⅰ  (underline) restriction sites: 
5’-gatcagatctgctggaaagagagcaaggaaagc-3’, 5’-tcccccgggccttatcccgaaggcttgg 
aaatttgcc-3’.  The amplified products (predicted to be 3582bp (1194aa) for the 
nsp2 gene from LP-PRRSV strain CH-1R and 3492bp (1164aa) from 
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HP-PRRSV strain SD-16) were ligated into the pEGFP-C1 vector to produce 
the recombinant plasmids EGFP-LPnsp2 and EGFP-HPnsp2. 
 
Transfection  
293T cells were seeded and were 50% confluent prior to transfection.  
For 10 cm dishes 10 µg of recombinant plasmids and 61µl of CaCl2 (2M) were 
diluted into ddH2O to make 500 µl mixture.  The mixtures were added into the 
same volume of 2X HBS (50mM HEPES, 280mM NaCl, 1.5mM Na2HPO4, pH 
7) and incubated for 30 minutes at room temperature.  The final mixtures 
were added dropwise to the cells with the volume of 1 ml. Then the cells were 
grown at 37°C, 5% CO2 for 24 hours.  For 12-well plates, 0.71 µg of DNA and 
4.37µl of 2 M CaCl2 were mixed with 36 µl 2X HBS instead.  A total of 72 µl 
mixture was added to the cells. Monolayer MARC-145 and PK-15 cells were 
transfected with Lipofectamine 2000 (Sigma) according to the instruction.   
 
GFP pull downs 
293T cells were transfected with plasmids EGFP-LPnsp2 and 
EGFP-HPnsp2 using the calcium phosphate method, using four 10 cm dishes 
per plasmid.  Cells were harvested 24 h post-transfection in lysis buffer (10 
mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% (v/v) NP40) with halt 
protease inhibitor (Fisher Scientific) at a final concentration of 1X.  Clarified 
cell lysates were incubated with GFP-trap beads (Chromo Tek) for 2 h at 4°C 
before three washes with 10 mM Tris HCl, pH 8, 0.1% NP-40, 150 mM NaCl, 
0.5 mM EDTA.  For LC-MS/MS analysis, the bound proteins were eluted with 
100 µl of glycine elution buffer (0.2 M glycine, pH 2.5), the supernatant was 
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collected and neutralized with 10 µl of 1M Tris base (pH 10.4).  Samples were 
prepared separately in triplicate.  For western blotting analysis, bound 
proteins were eluted with 100 µl 2x SDS-Sample buffer.  RFP-Trap coupled 
agarose beads were used as a negative control.  
 
Sample preparation for proteomics 
The glycine buffer eluted samples were diluted two fold with 25 mM 
ammonium bicarbonate.  Rapigest (Waters) was added to a final 
concentration of 0.05% (w/v) and the sample was heated at 80°C for 10min. 
Proteins were reduced with 3 mM dithiothreitol (Sigma) at 60°C for 10min then 
alkylated with 9 M iodoacetimide (Sigma) at room temperature for 30min in the 
dark. Proteomic grade trypsin (0.2µg, Sigma) was added and samples were 
incubated at 37°C overnight.  The Rapigest was removed by adding TFA to a 
final concentration of 1% (v/v) and incubating at 37°C for 2h.  Peptide 
samples were centrifuged at 12,000g, 4°C for 1h to remove precipitated 
Rapigest.  Each digest was concentrated and desalted using C18 Stage tips 
(Thermo scientific), then dried down using a centrifugal vacuum concentrator 
(Jouan) and resuspended in a 0.1% (v/v) TFA, 3% (v/v) acetonitrile solution. 
 
NanoLCMSESI MS/MS analysis 
Peptide mixtures (2µl) were analyzed by on-line nanoflow liquid 
chromatography using the nanoACQUITY-nLC system (Waters MS 
technologies, Manchester, UK) coupled to an LTQ-OrbitrapVelos 
(ThermoFisher Scientific) mass spectrometer equipped with the 
manufacturer’s nanospray ion source.  The analytical column (nanoACQUITY 
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UPLCTM BEH130 C18 15cm x 75µm, 1.7µm capillary column) was 
maintained at 35°C and a flow-rate of 300nl/min. The gradient consisted of 
3-40% acetonitrile in 0.1% formic acid for 50 min then a ramp of 40-85% 
acetonitrile in 0.1% formic acid for 3 min.  Full scan MS spectra (m/z range 
300-2000) were acquired by the Orbitrap at a resolution of 30,000 with 
precursor  isolation width of 1.2 m/z. Analysis was performed in data 
dependent mode.  The top 20 most intense ions from MS1 scan (full MS) 
were selected for tandem MS by collision induced dissociation (CID) at 
normalized CE 35%, and all product spectra were acquired in the LTQ ion trap. 
Charge state rejection was enabled where charge state one was rejected and 
dynamic exclusion was enabled at repeat count one, repeat duration 20 and 
exclusion duration 20. 
Thermo RAW files were imported into Progenesis LC–MS (version 4.1, 
Nonlinear Dynamics).  Runs were time aligned using default settings and 
using anauto selected run as reference.  Peaks were picked by the software 
and filtered to include only peaks with a charge state of between +2 and +6. 
Peptide intensities were normalised against the reference run by progenesis 
LC-MS and these intensities are used to highlight differences in protein 
expression between GFP control and GFP-nsp2 samples with supporting 
statistical analysis (ANOVA p-values) calculated by the Progenesis LC-MS 
software. MS.  Spectral data were transformed to mgf files with Progenesis 
LC–MS and exported for peptide identification using the locally installed 
PEAKS Studio 7 (Bioinformatics Solutions Inc.) search engine.  Multiple 
search engine platform provided by PEAKS Studio named inChorus was used, 
which combines searching results from PEAKS DB (Bioinformatics Solutions 
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Inc.), locally installed Mascot (v2.3, Matrix Science) and OMSSA (National 
Center for Biotechnology Information) and X!Tandem (Global Proteome 
Machine Organization) that were bundled with PEAKS Studio 7.  Tandem MS 
data were searched against the human and PRRSV predicted proteomes 
custom database that contained the common contamination (The Global 
Proteome Machine, version 2012.01.01, 115 sequences) and internal 
standards (MassPREP Digestion Standard Mix 2, Waters, 4 sequences), host 
cell proteome sequences (UniProt reviewed, version February 2014, 20,276 
sequences) and viral sequences (GenBank JX087437).  Search parameters 
were as follows; enzyme set to trypsin, precursor mass tolerance set to 10 
ppm and fragment mass tolerance set to 0.5 kDa.  One missed tryptic 
cleavage was permitted.  Carbamidomethylation (cysteine) was set as a fixed 
modification and oxidation (methionine) set as a variable modification.  The 
false discovery rates were set at 1% and at least two unique peptides were 
required for reporting protein identifications. Results were imported into 
Progenesis LC–MS as .xml files 
 
Immunoprecipitation (IP) 
293T cells were transfected with the plasmids using calcium phosphate. 
The cell lysates were prepared and incubated with 2 µg of anti-14-3-3 (Abcam, 
ab6081, rabbit polyclonal antibody), anti-DNAJA2 (Santa Cruz, sc-136515, 
mouse monoclonal antibody), anti-nucleolin (Abcam, ab13541 mouse 
monoclonal antibody) anti-CD2AP(Cell Signaling, A599, rabbit polyclonal 
antibody), anti-HSP70 (Sigma, H5147, mouse monoclonal antibody), or 
anti-ribosomal protein S6 (FL-249) (Santa Cruz, sc-20085, rabbit polyclonal 
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antibody) antibodies overnight on a rotator at 4°C before precipitation by the 
addition of 50 µl protein G resin (Gneron) for a further 2h.  After washing, 
bound proteins were eluted with 100 µl 2x SDS-Sample buffer. 
 
Western blotting 
Samples were separated by 10-15% SDS-PAGE and transferred to PVDF 
membranes (Millipore) using a Bio-Rad semi-dry transfer apparatus according 
to standard procedures.  The primary antibodies were anti-GFP (Santa Cruz, 
sc8334) and all the antibodies mentioned in IP method.  HRP-conjugated 
anti-mouse or anti-rabbit secondary antibodies were purchased from sigma. 
Blots were imaged by using ClarityTM Western ECL subtract (BIO-RAD). 
 
Aggresome detection and microscopy  
293T, MARC-145 and PK-15 cells were seeded onto coverslips and 
transfected with plasmids pEGFP-C1, EGFP-LPnsp2 and EGFP-HPnsp2 by 
Lipofectamine 2000 (Invitrogen), respectively.  MARC-145 cells were infected 
with PRRSV strains at 0.01 MOI.  Twenty-four hours post-transfection or 
post-infection the cells were fixed with 4% paraformaldehyde and 
permeabilised with 0.1% (v/v) triton X-100 in phosphate buffered saline.  For 
aggresome detection, cells were incubated with aggresome detection reagent 
and Hoechst 33342 supplied by Aggresome Detection Kit (Abcam, ab139486).  
Transfected 293T and MARC-145 cells were probed with anti-14-3-3, 
anti-CD2AP, anti-HSP70 (mentioned above) and anti-vimentin (Abcam, 
ab92547, rabbit monoclonal antibody) antibodies. Transfected PK-15 cells 
were probed with anti-14-3-3 and anti-CD2AP antibodies.  The proteins were 
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visualized with either Alexa Fluor®568 rabbit anti-mouse or Alexa Fluor® 546 
donkey anti-rabbit antibodies (Life Technologies).  PRRSV infected 
MARC-145 cells were incubated with anti-HP-PRRSV SD16 pig hyper 
immunized serum which was prepared by artificial infection of HP-PRRSV 
SD16 strain under lab condition, and visualized with FITC-goat anti-pig IgG 
and 14-3-3 protein was visualized by Cy3-goat anti-rabbit IgG (Jackson).  All 
probed cells were observed under fluorescence microscope (Carl Zeiss 
Upright Axio Lab.A1). 
 
Analysis of soluble and insoluble fractions 
293T cells were transfected with pEGFP-C1, EGFP-LPnsp2 and 
EGFP-HPnsp2. Twenty-four hours post-transfection, cells were collected by 
cell scraper and washed three times with PBS.  The cells were then lysed in 
lysis buffer with halt protease inhibitor for 30 min on ice before clarification by 
centrifugation at 1,000×g, 3 min to remove cell debris.  The supernatant was 
collected and centrifuged at 20,000×g for 30 min and both the supernatant and 
pellet saved.  The pellet was washed twice with RIPA buffer (NP40:1%, 350 
mM Tris-HCL, 150 mM NaCl, 0.1% SDS).  The insoluble parts were collected 
by centrifugation with 20,000 ×g for 1 h and resolved in 8M urea lysis buffer 
(Urea 8M, DTT 1M, Tris 1.5M, 0.1% SDS, Glycerol 10%,).  The same 
volumes were loaded onto SDS-PAGE for western blot analysis. 
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Results  
Expression of EGFP-HPnsp2 and EGFP-LPnsp2 in 293-T cells and 
interaction analysis. 
To determine the interactome of the HP-PRRSV nsp2 protein, a combined 
EGFP-trap LC-MS/MS approach was used, similar to the approach we have 
used to elucidate the interactomes of other viral proteins, including human 
respiratory syncytial virus (HRSV) NS1 and L proteins , infectious bronchitis 
virus and PRRSV nucleocapsid proteins, and Ebola virus VP24.26-30  The 
nsp2 gene of HP-PRRSV was cloned downstream of the EGFP gene to direct 
expression of a fusion protein consisting of EGFP N-terminal to nsp2 
(EGFP-HPnsp2).  Cell lysates were prepared from cells expressing 
EGFP-HPnsp2 or EGFP alone, and the GFP proteins purified by EGFP-trap 
chromatography to pull down associated cellular proteins.  Label free 
LC-MS/MS was used to identify and quantify the abundance of these with the 
expectation that specific interaction partners of nsp2 would be selectively 
enriched in the EGFP-HPnsp2 samples. 
Despite PRRSV infecting swine and naturally replicating in porcine 
alveolar macrophages (PAMs), human 293T cells were used to derive 
potential interactomes for several reasons.  (1). 293T cells are highly 
susceptible to calcium phosphate transfection of plasmids allowing almost 
ubiquitous high expression of the recombinant protein for analysis.  (2). 
Protein identification can be referenced to human databases that are more 
complete that swine databases.  (3). Many studies on PRRSV use the 
MARC-145 simian cell line as one of the few cell lines that reliably supports 
PRRSV replication.  (4). PAMS are refractive to expression of exogenous 
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proteins.  (5). It is hard to justify the number of PAMs required for biochemical 
experiments under the replacement, reduction and refinement in animal 
research, when other model systems (such as 293T cells can be used). 
The expression of EGFP, EGFP-HPnsp2 and EGFP-LPnsp2 were 
confirmed in 293 T cells by both direct fluorescence (Figure 1A) and western 
blot (Figure 1B).  All three proteins were expressed in similar numbers of 
cells, while western blot analysis showed that the full-length fusion proteins 
were the expected molecular weight (Figure 1B). EGFP-LPnsp2 expression 
also produced several lower molecular weight products (Figure 1B), possibly 
associated with cleavage of the protein.  A highly specific GFP-trap was used 
to selectively precipitate EGFP and the EGFP fusion proteins. Pull down 
products from these trap experiments were digested with trypsin after adding 
RapiGest to optimize in-solution protein digestion.  The peptides were 
desalted and enriched for analyzing by label-free quantitative proteomics. 
To provide a statistically robust dataset, pull downs with both the EGFP 
control and EGFP-HPnsp2 were performed independently in duplicate.  The 
abundance of bound peptides from the EGFP and EGFP-HPnsp2 traps were 
compared by Progenesis LC–MS software against a human database.  The 
use of quantitative label free proteomics allowed assignment of proteins that 
bound to either EGFP and/or the binding matrix compared to proteins that 
bound to the EGFP-HPnsp2.  Selection criteria for potential interacting 
partners for HPnsp2 included a False Discovery Rate (FDR) ≤1% two or more 
unique peptides for reporting protein identifications and a binding ratio greater 
than 2-fold. 
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The identified proteins from each experiment are combined and shown in 
Table One.  These proteins were analysed using the STRING algorithm in 
order to investigate potential interactions.  After enrichment of KEGG 
Pathways, these proteins were divided into 4 categories: the distinct ribosomal 
complex cluster composed of 40 ribosomal proteins, the smaller cluster 
composed by 5 isoforms of 14-3-3 protein which play an important role in 
signaling pathways, four proteins (SSRG, SSRD, DNAJA2 and PDIA3) 
involved in protein processing in endoplasmic reticulum and unassigned 
proteins such as CTBP2, CD2AP, and NUCL.  Analysis using Ingenuity 
Pathway Analysis highlighted several proteins which could be clustered into 
similar functions including those involved in gene expression (EIF3I, RBM3, 
RBM4, CDK6, CTPBP2 and PHB2), protein synthesis (EIF3I, RBM3, RBM4 
and PDIA3) and apoptosis (CD2AP, CDK6, COX5A, CTBP2, EIF3I, PDIA3, 
PHB2 and RBM3). 
Validation of the EGFP-HPnsp2 interactome. 
The LC-MS/MS identified several different sets of proteins, so selected 
interactions were validated in repeat GFP trap pull downs, but using antibodies 
to specific proteins to confirm interactions using western blot (Figure 2A).  As 
further controls of specificity, EGFP-LPnsp2 was also tested as a bait 
polypeptide, while negative controls were no EGFP bait, EGFP only as bait, or 
using RFP trap beads (which would not be expected to enrich the bait 
polypeptides) in the presence of the nsp2 fusion proteins. Cellular target 
proteins were selected on the basis of variability in peptides used for 
identification, difference in ratio between EGFP and EGFP-HPnsp2 and 
bioinformatic analysis of function. This led to the choice of RS6 (3 peptides, 
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13.5-fold enhanced) from the ribosomal protein cluster, 14-3-3 (5 peptides, 
6.7-fold enhanced) from the 14-3-3 family cluster, DNAJA2 (2 peptides, 
4.71-fold enhanced) in the protein processing in endoplasmic reticulum cluster 
and selected examples of unassigned proteins: CD2AP (12 peptides, 11.7-fold 
enhanced) and NUCL (23 peptides, 5. 6-fold enhanced). HSP70 (4 peptides, 
1.5-fold enhanced) was also investigated.  Blotting for GFP showed that as 
expected, the GFP bait polypeptides were efficiently pulled down by the GFP 
trap beads, but not the RFP trap beads (Figure 2A, top two rows). 
Unambiguous specific binding of nucleolin, CD2AP, HSP70, and DNAJA2 to 
both HP and LP nsp2 polypeptides but none of the negative controls was 
observed. Evidence of similar binding of the ribosomal RS6 protein was also 
seen, but the poor quality of the available antibody lessened the 
signal-to-noise ratio of the data.  Clear binding of 14-3-3 to the EGFP-HPnsp2 
protein was also seen, but not to the counterpart LP fusion protein, whose 
binding to this protein was no different to that of the EGFP only control (Figure 
2A). 
A reverse pull down approach was also used to confirm interactions, in 
which antibodies to the specific cellular proteins were tested for their ability to 
precipitate the EGFP-tagged nsp2 proteins (Figure 2B).  The binding of these 
proteins to either EGFP-HPnsp2 or EGFP-LPnsp2 was compared to an EGFP 
control.  The data indicated that both EGFP-HPnsp2 and EGFP-LPnsp2, but 
not EGFP, associated with NUCL, CD2AP, HSP70, DNAJA2, and 14-3-3.  
RS6 protein precipitated EGFP-HPnsp2 but EGFP-LPnsp2 was either below 
the limit of detection or did not bind to it.  Thus overall, the interaction of each 
of the chosen cellular proteins with both HP and LP PRRSV nsp2 was 
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validated by specific biochemical assays, although potentially, some 
strain-dependent variation was seen in the 14-3-3 and RS6 interactions. 
Confocal microscopy was then used as an independent approach to 
explore potential interactions between either EGFP-HPnsp2 or EGFP-LPnsp2 
and the cellular proteins (where antibody combinations allowed), again using 
EGFP as a control (Figure 3).  These three exogenous proteins were over 
expressed separately in 293T cells (used for the pull down), MARC-145 cells 
(a permissive cell line for PRRSV) or PK-15 cells (a porcine derived cell line).  
The data indicated that for both cell lines EGFP-HPnsp2 and EGFP-LPnsp2 
potentially interacted with 14-3-3 and CD2AP and shared similar locations in 
the cell.  These two cellular proteins did not co-localise with EGFP.   The 
co-localization of nsp2 protein with 14-3-3 and CD2AP in PK-15 cells, further 
confirmed that nsp2 could interact with 14-3-3 and CD2AP (Figure 3).  There 
was no evidence for co-localization between either EGFP-HPnsp2 or 
EGFP-LPnsp2 and RS6. 
Interactions between nsp2 and cellular proteins occur in 
virus-infected cells.  The interactome data for nsp2 was generated in the 
context of over-expression of the isolated viral polypeptide.  To investigate 
whether these interactions occurred in PRRSV infected cells where nsp2 is 
expressed in a native context in the presence of other viral proteins we made 
use of a recombinant LP-PRRSV (Type 1 genotype) that expressed nsp2 as a 
biologically active EGFP fusion protein (termed in this study 
PRRSVnsp2-EGFP).  MARC-145 cells were either mock-infected, infected 
with PRRSVnsp2-EGFP or, to provide a negative control, transfected with 
EGFP, and cell lysates prepared for GFP trap pull downs (Figure 4A).  
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Precipitation of specific cellular protein targets was investigated by western 
blot.  Examination of the input cell lysates showed that antibodies raised 
against human isoforms of HSP70, 14-3-3, NUCL and CD2AP the equivalent 
polypeptides from the MARC-145 cell line.  None of these proteins interacted 
detectably with the EGFP control nor were present in the bound mock-infected 
sample (Figure 4A).  In contrast, HSP70, 14-3-3 and NUCL were all trapped 
by nsp2-EGFP expressed in the context of recombinant PRRSV infection.  
However, CD2AP, which associated with overexpressed EGFP-HPnsp2 or 
EGFP-LPnsp2, either did not associate with EGFP-nsp2 in the viral context or 
did so below the limits of detection.  The interaction of 14-3-3 with PRRSV 
was also investigated in MARC-145 cells infected with either LP-PRRSV or 
HP-PRRSV (Figure 4B).  The data indicated that 14-4-3 accumulated at the 
sites of virus replication and co-localized with viral proteins (Figure 4B).  This 
may also resemble the re-localization of 14-3-3 observed in some cases with 
over-expression of nsp2. 
Nsp2 associates with cellular aggresomes. 
The interactome analysis indicated that both HPnsp2 and LPnsp2 formed 
interactions with a number of proteins involved in the formation of aggresomes, 
31 including chaperone and 14-3-3 proteins.  Whilst aggresomes are part of 
the misfolded protein response, a number of viruses initiate and use and form 
these complexes to facilitate virus replication.32,33  For example, the 
cytomegalovirus UL76 protein initiates aggresome formation.34  To 
investigate whether aggresomes formed in the presence of nsp2 we used 
complementary imaging and biochemical approaches to examine the 
aggresome complex.  First, to identify the aggresome complex in either cells 
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expressing either EGFP-HPnsp2, EGFP-LPnsp2 or EGFP (as a control), cells 
were treated with a dye that becomes fluorescent when bound to aggregated 
cargo35 and imaged by confocal microscopy (Figure 5A). The data indicated 
that in both 293T and MARC-145 cells, both EGFP-HPnsp2 and 
EGFP-LPnsp2 co-localized with the marker for the aggresome (as determined 
by the yellow signal in the merged image) (Figure 5A).  To investigate this 
further, two components of the aggresome, HSP70 and vimentin, were 
visualized in 293T and MARC-145 cells expressing EGFP-HPnsp2, 
EGFP-LPnsp2 or EGFP (as a control) (Figure 5B).  The data indicated that 
EGFP-HPnsp2 and EGFP-LPnsp2 could co-localize with either HSP70 or 
vimentin, whereas EGFP did not (Figure 5B). 
Recently, 14-3-3 has been reported to target misfolded 
chaperone-associated proteins to aggresomes by acting as an adaptor along 
with an HSP70 co-chaperone, Bcl-2-associated athanogene 3 (BAG3) to 
recruit chaperone-associated protein cargos to dynein motors for their 
transport to aggresomes.36  In the GFP-nsp2 pull down, seven different 
isoforms of 14-3-3, HSP70 and DNAJA2 were identified as potentially 
interacting with nsp2.  We therefore hypothesised that 14-3-3 might play a 
key role in the formation of chaperone-dependent nsp2 aggresomes.  To test 
this, we isolated detergent-insoluble cell fractions37 expected to be enriched for 
aggresomes from 293T cells transfected with the EGFP polypeptides and 
probed the distribution of EGFP, CD2AP, HSP70, DNAJ2, 14-3-3 and (as a 
control), GAPDH (Figure 6).    As expected, GAPDH was not detectable in 
the insoluble fractions, indicating the reliability of this isolation method. 
EGFP-HPnsp2 and EGFP-LPnsp2 were detected in both the soluble and the 
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insoluble fraction, whereas EGFP was only detected in the soluble fraction, 
despite its higher expression level (Figure 6). This is consistent with the nsp2 
polypeptide contributing to aggresome formation. A fraction of HSP70 was 
present in the insoluble fraction in EGFP-transfected cell lysates, but the 
proportion increased in the nsp2-transfected samples. Furthermore, CD2AP, 
DNAJA2, different 14-3-3 isoforms were only identified in the insoluble fraction 
in the presence of the EGFPnsp2 polypeptides. This result is consistent with 
the hypothesis that CD2AP, DNAJA2 and HSP70 as well as 14-3-3 
polypeptides participate in nsp2 aggresome formation. 
To determine whether CD2AP, DNAJA2 and HSP70 interact with 14-3-3, 
a reverse pull down was performed using the 14-3-3 antibody (Figure 6). 
CD2AP was not detected in the pull down product while both DNAJA2 and 
HSP70 were detected, indicating 14-3-3 only interacted with DNAJA2 and 
HSP70 but not CD2AP. 14-3-3 and HSP70 interacted with both EGFP and 
EGFP-HPnsp2 while DNAJA2 interacted with EGFP-HPnsp2. 
Specific domains of nsp2 interact with cellular protein targets. 
The interactome data indicated that nsp2 interacts with multiple protein 
targets; suggesting this protein may act as a hub protein, behavior sometimes 
expected for conformationally versatile proteins with disordered regions 37. A 
protein disorder prediction algorithm did indeed suggest the existence of 
disordered regions within the HPnsp2 polypeptide, with the most disordered 
region corresponding to the HV region (amino acids 160-814) (Figure 7).  To 
test whether different domains of HPnsp2 interacted with specific cellular 
proteins, the the OTU, HV, TM and Tail regions were expressed as separate 
EGFP fusion proteins (Figure 8A).  Immunofluorescence (Figure 8B) and 
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western blot (Figure 8C) analysis indicated that all fragments of nsp2 were 
successfully expressed in 293T cells, although the TM construct accumulated 
to noticeably lower levels than the rest.  
The ability of the individual nsp2 domains to bind nucleolin, CD2AP, 
HSP70, DNAJ2 and 14-3-3 was then tested by GFP trap analysis and western 
blot as before. (Figure 9A). As a further control to assess specificity, the 
association of the EGFP-HPnsp2 polypeptides with HSP90 was also examined.  
HSP90 was not identified in the interactome analysis as binding to 
EGFP-HPnsp2, and therefore would not be predicted to interact with full length 
or individual domains of nsp2.  Western blot analysis confirmed this prediction 
(Figure 9A). The EGFP control also failed to precipitate any of the cellular 
targets, as expected. In contrast, all five potential nsp2 interaction partners 
were precipitated by the full length EGFP-HPnsp2 polypeptide. HSP70 bound 
to all subfragments of nsp2 other than the TM domain, although the poor 
expression of the latter construct prevented firm conclusions about its 
behaviour. DNAJA2 did not bind to any of the individual nsp2 domains, while 
nucleolin, CD2AP and 14-3-3 all bound specifically to the HV region. Thus the 
HPnsp2 HV region functions to bind multiple cellular polypeptides, consistent 
with the concept that it acts as a binding hub. 
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Discussion 
Many viruses such as PRRSV synthesize large polyproteins that are then 
cleaved into functional sub-units.  For PRRSV and related arteriviruses and 
coronaviruses these proteins are involved in the replication and transcription of 
the viral genome, virus biology and modulation of host cell biology.  Here we 
investigated the interaction of the nsp2 protein encoded by the PRRSV ORF1a 
gene as part of a larger polyprotein.  The precise role of nsp2 in virus biology 
has not been defined and recent data has shown the protein is also 
incorporated in virus particles.22  To investigate the cellular interactome of 
nsp2, proteins were expressed from low and highly pathogenic variants of 
PRRSV (Figure 1).   Several LPnsp2 isoforms were detected, while there 
was one specific species associated wih the expression of HPnsp2 (Figure 1B). 
Therefore, in this work we focused on the interaction between HPnsp2 and the 
host cell, by first determining the cellular interactome of the nsp2 protein 
expressed from a highly virulent form of PRRSV. PRRSV nsp2 has recently 
been shown to interact or be part of a complex with potentially 285 cellular 
proteins.38 In this study the authors used an immuno-precipitation approach 
and separation of products by SDS-PAGE and protein identification using MS.  
Our approach differed slightly from this analysis, in that we used a label free 
quantitative proteomic approach to identify potential binding partners.  Our 
analysis identified 91 proteins that we assigned as having a potential 
interaction with HPnsp2.  Several proteins were common to both studies; 
CTBP2, SSRG, CD2AP, RBM4, 14-3-3G, RL7A. RS7, NUCL, RL18A, RL13, 
14-3-3E and lower order hits (in our study) such as ADT2, RL9, RL8, ILF3, 
RS3, PABP1, RPN1, 14-3-3T, HSP72, THOC4, HSP7C and HSP71.  Binding 
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of nsp2 to a number of identified targets (NUCL, CD2AP, HSP70, DNAJA2, 
14-3-3 and RS6) was confirmed using forward and reverse pull downs in 
separate repeat experiments (Figure 2) and immunofluorescence (Figure 3), 
placing confidence in the label free approach to correctly identify potential 
protein-protein interactions with HPnsp2. 
14-3-3 is a highly conserved, ubiquitously expressed protein family. 
14-3-3 proteins are involved in important cellular processes such as signal 
transduction, cell cycle control, apoptosis and the stress response by binding 
at least 100 different proteins.39  Two phosphorylated consensus sequences 
were identified as 14-3-3 protein binding motifs40, although these motifs are 
not found in nsp2. However, a non-consensus motif RX1-2SX2-3S (x 
represents any amino acid) was identified in 14-3-3 binding partner of Cbl41 
and can also be found in nsp2..  14-3-3 may associate with the HV domain of 
nsp2 as indicated (Figure 9).  14-3-3 may have multiple roles42 including as 
an adaptor molecule to facilitate protein-protein interactions.  We postulate 
that 14-3-3 can act as an adaptor with nsp2.  CD2AP was an adaptor protein 
which belongs to the CIN85/CD2AP and can act as a hub proteins43 and play 
an integral role in actin remodeling.44 The binding of CD2AP and nsp2 protein 
may change the structure of actin which facilitated the formation of 
aggresomes. 
Our data indicated that nsp2 could associate with a number of cellular 
proteins involved in the formation of aggresomes.  In virus-infected cells 
these have been associated with sites of virus replication and/or assembly.33  
This was investigated using a number of different complementary approaches 
included immunofluorescence (e.g. Figure 5) and biochemical analysis (e.g. 
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Figure 6).  Both approaches indicated that nsp2 was associated with 
aggresomes. 
Ribosomal proteins were also found to potentially interact with nsp2 and 
this may point towards a role of nsp2 in the modulation of this cellular activity 
and perhaps promotion of translation of viral gene products.  Not all 
protein-protein interactions that nsp2 could form with cellular proteins were 
investigated and the proteomic approach provides a wealth of data that can be 
further investigated to probe PRRSV host cell interactions and the role of nsp2 
in virus biology.  For example, the data indicated that HPnsp2 formed an 
interaction with CTBP2 (C-terminal-binding protein 2).  This is a 
transcriptional co-repressor that turns target genes off and is a potential target 
for viral intervention.  Transcription of the mRNA encoding this protein has 
recently been shown to be repressed by Epstein-Barr virus (EBV) infected 
cells by the EBNA 3 protein.45 Control of sub-cellular localisation is also 
emerging as an important mechanism whereby CTBP2 function is regulated. 
CTBP2 binds to client proteins through a PXDLS amino acid motif on the 
client. Analysis of the nsp2 amino acid sequence for both HPnsp2 and LPnsp2 
and other strain variants indicates a conserved PXDLS motif, in this case 
PLDLS.  
Analysis of the primary amino acid sequence of HPnsp suggested that it 
could potentially act as a hub protein with the HV region having the most 
disordered structure to facilitate protein-protein interactions (Figure 7).46  The 
data indicated that CD2AP and 14-3-3 could form a protein-protein interaction 
with this region, but not the other regions that constitute HPnsp2.  All seven 
isoforms of 14-3-3 were found to interact with HPnsp2 in our study. 
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In conclusion, the interactome analysis suggested that PRRSV nsp2 
formed multiple cellular protein interactions that may have multiple implications 
for both viral and host cell biology.  Targeting the function of these cellular 
proteins that may be critical for virus biology, with small molecular inhibitors, 
can be used as potential anti-viral therapy. 
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 Table 1 Cellular proteins showing more than 2 fold changes in abundance compared GFP-nsp2 with GFP 
 
Protein 
identifier 
Protein 
name 
Peptides Max 
fold 
change 
Anova 
(p) 
Protein function(s) Molecular 
weight 
Standard 
error 
(Control) 
Standard 
error (SD16) 
Nsp2 Nsp2 155 42.35 0.012 Nsp2_SD16 126242 456142.4 82564079.2 
P56545 CTBP2 6 16.79 0.033 C-terminal binding protein 2; Corepressor 
targeting diverse transcription regulators. 
48945 6730.8 88111.9 
P62753 RS6 3 13.5 0.026 40S ribosomal protein S6; controlling cell 
growth and proliferation. 
28681 2749.5 92520.5 
P49207 RL34 3 11.88 0.001 60S ribosomal protein L34 13293 49.2 6375.3 
Q9UNL2 SSRG 2 11.68 0.013 Signal sequence receptor, gamma 
(translocon-associated protein gamma); 
part of a complex of binding calcium to the 
ER membrane and retention of ER resident 
proteins 
21080 245.5 4574.3 
Q9Y5K6 CD2AP 12 11.68 0.004 CD2-associated protein; an adapter protein 
between membrane proteins and the actin; 
71451 9697.0 6601.3 
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connect receptor clustering and 
cytoskeletal polarity in the between T-cell 
and antigen-presenting cell. 
P61254 RL26 5 9.09 0.001 60S ribosomal protein L26 17258 1394.1 1640.1 
P42766 RL35 3 8.85 0.029 60S ribosomal protein L35 14551 8105.0 8288.6 
P62899 RL31 5 8.66 0.013 60S ribosomal protein L31 14463 10338.4 83616.6 
O00264 PGRC1 2 7.7 0.118 Progesterone receptor membrane 
component 1; Receptor for progesterone 
21671 3800.2 4434.1 
Q9BWF3 RBM4 2 7.62 0.065 RNA binding motif protein 4; select 
alternative splice site during pre-mRNA 
processing 
40314 540.0 16293.1 
P98179 RBM3 3 7.28 0.029 RNA binding motif (RNP1, RRM) protein 3 17170 2347.0 571.5 
P62910 RL32 4 7.22 0.008 60S ribosomal protein L32 15860 7801.5 14830.9 
P31946 1433B 5 6.7 0.017 Tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, beta 
polypeptide; Adapter protein in the 
regulation of a large spectrum of both 
general and specialized signaling pathway; 
28082 4386.0 25272.1 
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modulates the activity of the binding 
partner, usually by recognition of a 
phosphoserine or phosphothreonine motif. 
P62750 RL23A 2 6.39 0.06 60S ribosomal protein L23a 17695 3457.9 11014.1 
P61981 1433G 6 6.17 0 tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, 
gamma polypeptide; similar function with 
1433B 
28303 365.5 1784.7 
P61353 RL27 2 6.14 0.026 60S ribosomal protein L27 15798 6713.3 90783.5 
P62424 RL7A 4 5.63 0.003 60S ribosomal protein L7a 29996 1349.9 9809.4 
P62081 RS7 9 5.61 0.02 40S ribosomal protein S7; Required for 
rRNA maturation 
22127 34601.3 309587.4 
P19338 NUCL 23 5.56 0.014 Nucleolin; induces chromatin 
decondensation; facilitates pre-rRNA 
transcription and ribosome assembly and 
transcriptional elongation. 
76614 136237.1 1163450.8 
P46779 RL28 11 5.52 0.004 60S ribosomal protein L28 15748 3223.1 59282.1 
Q02543 RL18A 4 5.46 0.005 60S ribosomal protein L18a 20762 1642.6 2944.9 
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P26373 RL13 9 5.42 0.007 60S ribosomal protein L13 24261 4649.1 182954.7 
P62263 RS14 4 5.4 0.03 40S ribosomal protein S14 16273 15012.6 104547.2 
P51571 SSRD 2 5.23 0.072 Translocon-associated protein subunit 
delta 
18999 2252.5 12540.3 
P82673 RT35 2 5.17 0.046 28S mitochondrial ribosomal protein S35 36844 1887.9 6548.9 
Q02878 RL6 3 5.14 0.033 60S ribosomal protein L6 32728 1523.0 34314.6 
O60884 DNJA2 2 4.71 0.063 DnaJ (Hsp40) homolog, subfamily A, 
member 2; Co-chaperone of Hsc70 
45746 3981.5 17105.1 
P84103 SRSF3 2 4.56 0.039 Splicing factor, arginine/serine-rich 3; 
involved in RNA processing in relation with 
cellular proliferation and/or maturation 
19330 4737.1 33604.1 
P62847 RS24 2 4.5 0.165 40S ribosomal protein S24;  subunit of 
processing of pre-rRNA and maturation of 
40S 
15423 1857.7 18473.8 
P46778 RL21 12 4.49 0 60S ribosomal protein L21 18565 699.9 28848.7 
P62258 1433E 6 4.4 0.003 tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, 
epsilon polypeptide; similar function with 
29174 2550.1 84910.6 
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1433B 
P46783 RS10 4 4.15 0.013 40S ribosomal protein S10 18898 5928.9 18457.0 
P62266 RS23 3 4 0.004 40S ribosomal protein S23 15808 421.4 2830.6 
P61513 RL37A 5 3.74 0.103 60S ribosomal protein L37a 10275 8014.2 16382.5 
P62273 RS29 2 3.55 0.021 40S ribosomal protein S29 6677 8117.6 10328.9 
P47914 RL29 5 3.52 0.018 60S ribosomal protein L29 17752 402.3 27449.9 
P60866 RS20 4 3.49 0.006 40S ribosomal protein S20 13373 5813.6 17178.3 
Q9NZI8 IF2B1 2 3.44 0 Insulin-like growth factor 2 mRNA binding 
protein 1; RNA-binding factor; stable 
mRNA 
63481 5.7 249.5 
Q9Y3U8 RL36 2 3.43 0.002 60S ribosomal protein L36 12254 1265.1 2049.9 
Q9NX63 CHCH3 2 2.98 0.285 Coiled-coil-helix-coiled-coil-helix domain 
containing 3 
26152 4577.7 7606.7 
P05141 ADT2 4 2.93 0.014 ADP/ATP translocase 2, catalyzes the 
exchange of ADP and ATP across the 
mitochondrial inner membrane 
32852 5358.2 71831.3 
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P62857 RS28 8 2.92 0.029 40S ribosomal protein S28 7841 9829.9 63533.9 
Q99623 PHB2 2 2.89 0.069 Prohibitin 2; mediator of transcriptional 
repression, Coregulator of estrogen 
receptor (ER) and represse the activity of 
estrogens; involved in regulating 
mitochondrial respiration activity and in 
aging 
33296 1116.6 10724.6 
P62829 RL23 4 2.88 0.216 60S ribosomal protein L23 14865 10755.2 27857.4 
P32969 RL9 5 2.84 0.049 60S ribosomal protein L9 21863 6206.3 48571.7 
P39019 RS19 2 2.77 0.016 40S ribosomal protein S19; Required for 
pre-rRNA processing and maturation of 
40S ribosomal subunits 
16060 1808.1 3878.6 
P13073 COX41 2 2.69 0.009 Cytochrome c oxidase subunit IV isoform 1; 
nuclear-coded polypeptide chains of 
cytochrome c oxidase, the terminal oxidase 
in mitochondrial electron transport 
19577 204.4 3891.7 
P62888 RL30 2 2.69 0.083 60S ribosomal protein L30 12784 5962.1 64807.6 
P35268 RL22 3 2.68 0.117 60S ribosomal protein L22 14787 5598.8 189963.8 
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P62249 RS16 6 2.63 0.019 40S ribosomal protein S16 16445 1147.6 18901.4 
Q8NC51 PAIRB 10 2.53 0.076 Plasminogen activator inhibitor 1 
RNA-binding protein; regulation of mRNA 
stability, binds to the 3'-most 134 nt of the 
SERPINE1/PAI1 mRNA. 
44965 39327.9 11552.6 
P37108 SRP14 2 2.52 0.018 Signal recognition particle 14kDa 
(homologous Alu RNA binding protein); 
portion of the SRP RNA, required for SRP 
RNA binding 
14570 1842.1 3482.2 
P62913 RL11 4 2.47 0.006 60S ribosomal protein L11; Binds to 5S 
ribosomal RNA. Required for rRNA 
maturation and formation of the 60S 
ribosomal subunits 
20252 69.0 3135.3 
P62917 RL8 5 2.45 0.013 60S ribosomal protein L8 28025 1264.7 11119.6 
Q04917 1433F 2 2.42 0.079 tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, eta 
polypeptide, similar function with 1433B 
28219 12217.4 12829.8 
P62280 RS11 12 2.39 0.011 40S ribosomal protein S11 18431 17724.4 2875.1 
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P83731 RL24 3 2.39 0.002 60S ribosomal protein L24 17779 98.3 67.5 
P63220 RS21 4 2.38 0.103 40S ribosomal protein S21 9111 10021.0 5755.4 
P0CW22 RS17L 6 2.23 0.108 40S ribosomal protein S17-like 15550 84630.2 348454.8 
Q13347 EIF3I 2 2.19 0.056 Eukaryotic translation initiation factor 3, 
subunit I; component of the eukaryotic 
translation initiation factor 3 (eIF-3) 
complex for the initiation of protein 
synthesis. 
36502 19.5 1413.3 
Q5JNZ5 RS26L 2 2.18 0.004 40S ribosomal protein S26-like 13002 1095.2 1349.6 
P63104 1433Z 5 2.16 0.105 Tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, zeta 
polypeptide; similar function with 1433B 
27745 13152.6 25667.6 
P20674 COX5A 2 2.14 0.075 Cytochrome c oxidase subunit Va; heme 
A-containing chain of cytochrome c 
oxidase, the terminal oxidase in 
mitochondrial electron transport 
16762 2784.1 239.8 
P25398 RS12 2 2.09 0.048 40S ribosomal protein S12 14515 1248.6 11021.0 
P30101 PDIA3 2 2.06 0.22 Protein disulfide isomerase family, A 56782 4355.4 12153.3 
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Figure legends 
Figure 1. Expression of EGFP-HPnsp2 and EGFP-LPnsp2 in 293T cells. The 
expression of EGFP fused nsp2 proteins were validated by fluorescence 
microscopy (A) and Western blot (B).  The predicted molecular size was 26.9, 
153,157 kDa for EGFP, EGFP-HPnsp2 and EGFP-LPnsp2, respectively. 
 
Figure 2. Validation of the interaction of nsp2 with cellular proteins by Western 
blot. (A)  Confirmation of the proteins associated with nsp2 in EGFP, 
EGFP-HPnsp2 and EGGP-LPnsp2 transfected 293T cells in GFP-trap 
pull-down using specific antibodies against 14-3-3, CD2AP, HSP70, DNAJA2, 
NUCL orRS6. A RFP-trap pull-down and non-transfected 293T cells were also 
used as the negative controls.  (B) Confirmation of the proteins associated 
with nsp2 by reverse immunoprecipitation. EGFP, EGFP-HPnsp2 and 
EGFP-LPnsp2 transfected 293T cell lysates were incubated with specific 
antibodies against NUCL, CD2AP, HSP70, DNAJA2, 14-3-3 and RS6 after 
pre-clearing with blank protein G resin, respectively. The existence of 
EGFP-HPnsp2 or EGFP-LPnsp2 in the input samples and the eluates were 
detected by a specific antibody against GFP. 
 
Figure 3. Co-localization of nsp2 with cellular proteins confirmed by 
immunofluorescence microscopy.  The co-localization of EGFP-HPnsp2 and 
EGFP-LPnsp2 with 14-3-3, CD2AP or RS6 was visualized in both transfected 
293T cells (used for the pull down), and MARC-145 cells (a permissive cell line 
for PRRSV). EGFP-HPnsp2 and EGFP-LPnsp2 were expressed in PK-15 cells 
(a porcine originated cell line) and 14-3-3 and CD2AP visualised. The 
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EGFP-tagged proteins were shown in green and cellular proteins were shown 
in red. The co-localization was determined by the yellow signal in the merged 
images. 
 
Figure 4. Validation of the interaction of nsp2 with cellular proteins in PRRSV 
infected MARC-145 cells.  (A) Western blot analysis of the input and bound 
samples by GFP-trap pull-down in MARC-145 cells either mock infected or 
infected with a European PRRSV-SD01-08 strain carrying a GFP reporter 
gene in nsp2 gene at a MOI of 3. MARC-145 cells transfected with EGFP-N1 
plasmid were used as a control for the proteins binding to EGFP. All cells were 
harvested 30hpi. Proteins interacting with nsp2 were pulled down by 
GFP-Trap. The pulldown samples were separated by SDS-PAGE and 
detected by specific antibodies against GFP, HSP70, 14-3-3, NUCL and 
CD2AP.  (B) Immunofluorescence microscopy showing the co-localization of 
14-3-3 and viral proteins. MARC-145 cells were either mock infected or 
infected with both type 2 LP-PRRSV CH-1R strain and HP-PRRSV SD16 
strain at an MOI 0.01. The cells were fixed at 24 hours post-transfection. 
PRRSV proteins were visualized with FITC-goat anti-pig IgG in green and 
14-3-3 were visualized with Cy3-goat anti-rabbit IgG in red. The co-localization 
was determined by the yellow signal in the merged images. 
 
Figure 5. Aggresome detection in EGFP, EGFP-HPnsp2 or EGFP-LPnsp2 
transfected 293T and Marc-145 cells.  (A) Co-localization of EGFP-HPnsp2 or 
EGFP-LPnsp2 with aggresomes maker proteins labelled by a novel 488 nm 
excitable red fluorescent molecular rotor dye which specifically detects 
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aggregated proteins within the aggresome and aggresome-like structures; (B) 
Co-localization of EGFP-HPnsp2 or EGFP-LPnsp2 with the aggresome 
component proteins HSP70 and Vimentin detected with anti-HSP70 and 
vimentin antibodies in red. The co-localization was determined by the yellow 
signal in the merged images. 
 
Figure 6. Identification of cellular proteins involved in aggresome formation by 
Western blot. EGFP, EGFP-LPnsp2 and EGFP-HPnsp2 transfected 293T cells 
were collected and lysed 24 hours post transfection.  (A) To separate cellular 
proteins that interacted with 14-3-3, the whole cell lysates were incubated with 
anti-14-3-3 antibody followed by protein G beads. The pull-down products 
were separated by SDS-PAGE and detected with specific antibodies against 
GFP, CD2AP, HSP70 and DNAJA2. (B) To enrich aggresomes, the whole cell 
lysates were centrifuged at high speed after brief centrifugation at low speed. 
The soluble fraction and insoluble fraction were collected. The insoluble 
fraction was collected after stringent wash with RIPA buffer and was solved in 
8M urea buffer.  The soluble and insoluble fractions were separated by 
SDS-PAGE and detected with specific antibodies against GFP, CD2AP, 
HSP70, DNAJA2, 14-3-3 and GAPDH. 
 
Figure 7. Prediction of the disorder region of PRRSV HPnsp2 protein using an 
online PrDOS protein disorder prediction system at a prediction false positive 
rate of 5%.   
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Figure 8. Expression of truncated HPnsp2 proteins in 293T cells 24 hour 
post-transfection.  (A) Schematic diagram of truncated nsp2 proteins with four 
concession fragments OTU, HV, TM, Tail spanning 47-159aa, 160-814aa, 
815-988aa, and 989-1164aa, respectively. (B) Expression of truncated 
HPnsp2 proteins visualized by direct fluorescence microscopy. (C) Western 
blot analysis of the truncated nsp2 proteins expressed in 293T cells and 
detection with a specific anti-GFP antibody. EGFP, OTU-EGFP, TM-EGFP, 
Tail-EGFP, HPnsp2-EGFP with predicted molecular weights of 26.9kDa, 
38.2kDa, 98.6kDa, 46kDa, 46.1kDa or 153.1kDa in order. 
 
Figure 9. Identification of specific domains of HPnsp2 interacting with cellular 
protein targets by western blot. 293T cells transfected with plasmids 
expressing each truncated HPnsp2 as well as full length HPnsp2 and EGFP as 
controls were harvested and lysed 24 hours post transfection and subjected to 
GFP-trap pull-down. The cellular proteins interacted with each truncated 
HPnsp2 protein was detected by specific antibodies against NUCL, CD2AP, 
HSP70, DNAJA2, 14-3-3 or HSP90 in both input samples and in the eluates. 
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